This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Bone Marrow Transplant Market

How is Advancement of Technology Affecting Bone Marrow Transplants? Key Insights By FMI

Bone Marrow Transplant Market by Transplantation Type, Disease Indication, End-user & Region- Forecast 2022 – 2032

Bone Marrow Transplant Market Outlook (2022-2032)

[308 Pages Report] The bone marrow transplant market is projected to have a sluggish CAGR of 3.4% during the forecast period. The current valuation of the bone marrow transplant market is US$ 10,355.73 million in 2022.

The market value of the bone marrow transplant market is anticipated to reach a high of US$ 14,527.05 million by the year 2032. A historical CAGR of 3.3% has been recorded by the experts of Future Market Insights for the concerned market.

The hematopoietic stem cell is a soft vascular tissue present in the interiors of long bones, and a bone marrow transplant is identified as the procedure to replace the damaged or destroyed bone marrow with healthy bone marrow stem cells.

Report Attribute

Details

Blow Molded Plastic Bottles Market Value (2022)

US$ 10,355.73 Million

Blow Molded Plastic Bottles Market Anticipated Value (2032)

US$ 14,527.05 Million

Blow Molded Plastic Bottles Projected Growth Rate (2022-2032)

3.4%

The bone marrow transplant procedure is prescribed for the treatment of advanced stages of leukemia, Hodgkin, and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia, and other diseases. Increasing awareness, combined with an increase in initiatives run by healthcare practitioners, is majorly responsible for the global growth of the bone marrow transplant market. Therefore, it is anticipated that the bone marrow transplant market is likely to witness significant growth during the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Market Scenario Analysis: Potential Drivers and Restraints

The market is anticipated to have mixed dynamics contributing to the bearish propulsion of the bone marrow transplant market. Several factors impacting the expansion of the market are identified during the study.

Besides the factor influencing growth, it is also identified that certain aspects can limit growth and curb the pace of growth further in the bone marrow transplant market.

DRIVERS

  • The major factor affecting the bone marrow transplant industry is the surge in the prevalence of blood cancer and other blood-related diseases. The statistics predicted by the experts of FMI are anticipated to help the forum propel over the forecast period.
  • The growing incidences of non-Hodgkin and Hodgkin lymphoma, thalassemia, and leukemia, along with the common bone marrow diseases around the world, the developments in technology, and the enhancement of the healthcare infrastructure are likely to drive the market in the long run.
  • A steep increase in the development of stem cell cryopreservation, which is identified to be the need of the hour is majorly contributing to the bone marrow transplant market and is likely to gain further traction in the upcoming years.
  • An increase in research and development activities is projected to boost the market, and new products are being launched that would help the industry flourish over the forecast period.
  • A rise in funding for logistic services and growing per capita healthcare expenses are expected to propel the growth of the market.

RESTRAINTS

  • It is identified that there is a high expenditure associated with the treatment, and the high cost of bone marrow transplant is likely to serve as deterring factor for the bone marrow transplant market, as a large section of the populace cannot afford such expensive treatment of the diseases.
  • There is a shortage of bone marrow donors is an aspect responsible for the impeding growth of the bone marrow transplant market in near future.
  • The lack of reimbursement policies for mainly organ transplantation procedures in emerging economies and developed countries is expected to hamper the growth of the industry during the period 2022-2032.

Regional Outlook

Overview of North America Bone Marrow Transplant Market

North America is projected to secure a steady growth in the bone marrow transplant market during the forecast period. Currently, the region is cumulatively holding a 32.4% market share of the global bone marrow transplant market.

The factors attributing to the growth can be mentioned as follows:

  • There is a growth in the healthcare infrastructure of North America, capital expenditures are initiated by the key players prevailing in this region, coupled with an installed base for different kinds of products for the bone marrow transplant market.
  • It is anticipated that the North American region is having favorable regulatory scenarios that are likely to impact the bone marrow transplant market positively.

European Region Bolstering the Global Bone Marrow Transplant Market

Europe is projected to dominate the global market for bone marrow transplants during the forecast period. At present, Europe is holding 50.4% of the total market share for bone marrow transplants worldwide.

The reasons owing for such extensive market expansion are mentioned below:

  • The increasing geriatric population of Europe is majorly driving the bone marrow transplant market as they are more prone to severe diseases.
  • The innovative healthcare systems have introduced bone marrow transplants in their contributions and the state-of-the-art public facilities which will further boost the growth of the bone marrow transplant market in the region during the forecast period.
  • New technology penetration in Europe is another factor majorly boosting the concerned market of the region.
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Start-Up Ecosystem

The start-ups in the bone marrow transplant market are indulging in collaborations and continually making innovations to the procedures of stem cells transplant to further make it convenient and cost-efficient for the population.

Top 3 Start-Ups to Watch for During the Forecast Period

Company Name

Magenta Therapeutics, Cambridge (US)

Total Funding

USD 151 Million

Description

Developer of stem cell-based therapies for autoimmune disease, genetic blood disorders, and cancer. The company has developed stem cell transplants by using targeted antibodies, stem cell harvesting using new biologic agents, and increasing stem cell numbers by targeting self-renewal pathways.

Company Name

Kiadis Pharma, Amsterdam (Netherlands)

Total Funding

USD 33 Million

Description

Kiadis Pharma is a developer of therapeutic solutions for hematopoietic stem cell transplants. It is focused on developing solutions for complications and limitations of hematopoietic stem cell transplants (HSCT) in blood cancer patients.

The company uses all depleted T-cell immunotherapeutics (ATIR) to support the patient’s newly transplanted immune system before it becomes fully functional. this enables better acceptance of even haploidentical (or lower) stem cell donors. Kiadis is investigating the use of ATIR in leukemia and thalassemia.

Company Name

Talaris, Boston (United States)

Total Funding

USD 215 Million

Description

Talaris Therapeutics is involved in developing single-dose cell therapy to treat living donor kidney transplant tolerance. They have developed a proprietary technology that allows candidates for bone marrow transplants to receive hematopoietic stem cells (HSCs).

The lead candidate FCR001 is in phase III clinical trial, which is being investigated for living donor kidney transplant tolerance.

Competitive Landscape

The bone marrow transplant market is highly competitive and consists of a number of major players. To increase their global market presence, market leaders are engaging in various product launches, mergers and acquisitions, and development activities focusing on orthopedic surgical treatments.

Recent Developments

Some of the recent developments identified in the analysis are:

  • In May 2020, Gamida Cell Ltd., an advanced cell therapy company committed to finding cures for blood cancer and serious blood diseases, declared positive topline results from its Phase 3 clinical study evaluating the safety and efficacy of omidubicel, investigational advanced cell therapy in development as a potentially life-saving treatment option for patients in need of bone marrow transplant.
  • In November 2019, Lonza Group Ltd. partnered with Cryoport, Inc. in the cell and gene therapy field and across Lonza's 'vein-to-vein' delivery network.
  • In September 2017, Inotek Pharmaceuticals entered into a definitive merger agreement with Rocket Pharmaceuticals, a U.S.-based gene therapy company.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Some of the key players proliferating in the current market

  • Lonza Group Ltd.
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • AllCells LLC.
  • STEMCELL Technologies
  • ATCC Inc.
  • Hemacare Corporation
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio, ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 3.4% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Transplantation Type
  • Disease Indication
  • End-User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Lonza Group Ltd.
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • AllCells LLC.
  • STEMCELL Technologies
  • ATCC Inc.
  • Hemacare Corporation
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio, ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.

Customization

Available Upon Request

Key Segments in the Bone Marrow Transplant Market

By Transplant Type:

  • Autologous Bone Marrow Transplant
  • Allogeneic Bone marrow Transplant

By Disease Indication:

  • Leukemia
  • Lymphoma
  • Myeloma
  • Others (anemia, thalassemia etc.)

By End-User:

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The growth outlook for the bone marrow transplant market is predicted to advance at a CAGR of 3.4% from 2022 to 2032.

The European region is anticipated to lead the bone marrow transplant market during the forecast period.

The bone marrow transplant market is likely to hold a valuation of US$ 14,527.05 million by 2032.

The healthcare sector is the key driver in the bone marrow transplant market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Transplant Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Transplant Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Transplant Type, 2022-2032

        5.3.1. Autologous

        5.3.2. Allogeneic

    5.4. Y-o-Y Growth Trend Analysis By Transplant Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Transplant Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Disease Indication, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032

        6.3.1. Leukemia

        6.3.2. Lymphoma

        6.3.3. Myeloma

        6.3.4. Others (Anemia, Thalassemia etc.)

    6.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Disease Indication, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Multispecialty Clinics

        7.3.3. Ambulatory Surgical Centers

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Transplant Type

        9.2.3. By Disease Indication

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Transplant Type

        9.3.3. By Disease Indication

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Transplant Type

        10.2.3. By Disease Indication

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Transplant Type

        10.3.3. By Disease Indication

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Transplant Type

        11.2.3. By Disease Indication

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Transplant Type

        11.3.3. By Disease Indication

        11.3.4. By End User

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Malaysia

            12.2.1.6. Singapore

            12.2.1.7. Australia

            12.2.1.8. New Zealand

            12.2.1.9. Rest of APAC

        12.2.2. By Transplant Type

        12.2.3. By Disease Indication

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Transplant Type

        12.3.3. By Disease Indication

        12.3.4. By End User

    12.4. Key Takeaways

13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Transplant Type

        13.2.3. By Disease Indication

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Transplant Type

        13.3.3. By Disease Indication

        13.3.4. By End User

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Transplant Type

            14.1.2.2. By Disease Indication

            14.1.2.3. By End User

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Transplant Type

            14.2.2.2. By Disease Indication

            14.2.2.3. By End User

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Transplant Type

            14.3.2.2. By Disease Indication

            14.3.2.3. By End User

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Transplant Type

            14.4.2.2. By Disease Indication

            14.4.2.3. By End User

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Transplant Type

            14.5.2.2. By Disease Indication

            14.5.2.3. By End User

    14.6. U.K.

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Transplant Type

            14.6.2.2. By Disease Indication

            14.6.2.3. By End User

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Transplant Type

            14.7.2.2. By Disease Indication

            14.7.2.3. By End User

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Transplant Type

            14.8.2.2. By Disease Indication

            14.8.2.3. By End User

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Transplant Type

            14.9.2.2. By Disease Indication

            14.9.2.3. By End User

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Transplant Type

            14.10.2.2. By Disease Indication

            14.10.2.3. By End User

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Transplant Type

            14.11.2.2. By Disease Indication

            14.11.2.3. By End User

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Transplant Type

            14.12.2.2. By Disease Indication

            14.12.2.3. By End User

    14.13. Malaysia

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Transplant Type

            14.13.2.2. By Disease Indication

            14.13.2.3. By End User

    14.14. Singapore

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Transplant Type

            14.14.2.2. By Disease Indication

            14.14.2.3. By End User

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Transplant Type

            14.15.2.2. By Disease Indication

            14.15.2.3. By End User

    14.16. New Zealand

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Transplant Type

            14.16.2.2. By Disease Indication

            14.16.2.3. By End User

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Transplant Type

            14.17.2.2. By Disease Indication

            14.17.2.3. By End User

    14.18. South Africa

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Transplant Type

            14.18.2.2. By Disease Indication

            14.18.2.3. By End User

    14.19. Israel

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Transplant Type

            14.19.2.2. By Disease Indication

            14.19.2.3. By End User

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Transplant Type

        15.3.3. By Disease Indication

        15.3.4. By End User

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Lonza Group Ltd.

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Merck Millipore Corporation

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Sanofi-Aventis LLC.

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. AllCells LLC.

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. STEMCELL Technologies

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. ATCC Inc.

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Hemacare Corporation

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Cellular Dynamics International

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. ReachBio LLC.

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Conversant Bio

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Market Value (US$ Mn) Forecast by Transplant Type, 2017-2032

Table 3: Global Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 4: Global Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 5: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Market Value (US$ Mn) Forecast by Transplant Type, 2017-2032

Table 7: North America Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 8: North America Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Market Value (US$ Mn) Forecast by Transplant Type, 2017-2032

Table 11: Latin America Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 12: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Market Value (US$ Mn) Forecast by Transplant Type, 2017-2032

Table 15: Europe Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 16: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 17: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Asia Pacific Market Value (US$ Mn) Forecast by Transplant Type, 2017-2032

Table 19: Asia Pacific Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 20: Asia Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 21: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: MEA Market Value (US$ Mn) Forecast by Transplant Type, 2017-2032

Table 23: MEA Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 24: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Transplant Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 3: Global Market Value (US$ Mn) by End User, 2022-2032

Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Market Value (US$ Mn) Analysis by Transplant Type, 2017-2032

Figure 9: Global Market Value Share (%) and BPS Analysis by Transplant Type, 2022-2032

Figure 10: Global Market Y-o-Y Growth (%) Projections by Transplant Type, 2022-2032

Figure 11: Global Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 14: Global Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 17: Global Market Attractiveness by Transplant Type, 2022-2032

Figure 18: Global Market Attractiveness by Disease Indication, 2022-2032

Figure 19: Global Market Attractiveness by End User, 2022-2032

Figure 20: Global Market Attractiveness by Region, 2022-2032

Figure 21: North America Market Value (US$ Mn) by Transplant Type, 2022-2032

Figure 22: North America Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 23: North America Market Value (US$ Mn) by End User, 2022-2032

Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Market Value (US$ Mn) Analysis by Transplant Type, 2017-2032

Figure 29: North America Market Value Share (%) and BPS Analysis by Transplant Type, 2022-2032

Figure 30: North America Market Y-o-Y Growth (%) Projections by Transplant Type, 2022-2032

Figure 31: North America Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 34: North America Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 37: North America Market Attractiveness by Transplant Type, 2022-2032

Figure 38: North America Market Attractiveness by Disease Indication, 2022-2032

Figure 39: North America Market Attractiveness by End User, 2022-2032

Figure 40: North America Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Market Value (US$ Mn) by Transplant Type, 2022-2032

Figure 42: Latin America Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 43: Latin America Market Value (US$ Mn) by End User, 2022-2032

Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Market Value (US$ Mn) Analysis by Transplant Type, 2017-2032

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Transplant Type, 2022-2032

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Transplant Type, 2022-2032

Figure 51: Latin America Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 54: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 57: Latin America Market Attractiveness by Transplant Type, 2022-2032

Figure 58: Latin America Market Attractiveness by Disease Indication, 2022-2032

Figure 59: Latin America Market Attractiveness by End User, 2022-2032

Figure 60: Latin America Market Attractiveness by Country, 2022-2032

Figure 61: Europe Market Value (US$ Mn) by Transplant Type, 2022-2032

Figure 62: Europe Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 63: Europe Market Value (US$ Mn) by End User, 2022-2032

Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Market Value (US$ Mn) Analysis by Transplant Type, 2017-2032

Figure 69: Europe Market Value Share (%) and BPS Analysis by Transplant Type, 2022-2032

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Transplant Type, 2022-2032

Figure 71: Europe Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 72: Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 74: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 77: Europe Market Attractiveness by Transplant Type, 2022-2032

Figure 78: Europe Market Attractiveness by Disease Indication, 2022-2032

Figure 79: Europe Market Attractiveness by End User, 2022-2032

Figure 80: Europe Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Market Value (US$ Mn) by Transplant Type, 2022-2032

Figure 82: Asia Pacific Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 83: Asia Pacific Market Value (US$ Mn) by End User, 2022-2032

Figure 84: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Market Value (US$ Mn) Analysis by Transplant Type, 2017-2032

Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Transplant Type, 2022-2032

Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Transplant Type, 2022-2032

Figure 91: Asia Pacific Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 94: Asia Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 97: Asia Pacific Market Attractiveness by Transplant Type, 2022-2032

Figure 98: Asia Pacific Market Attractiveness by Disease Indication, 2022-2032

Figure 99: Asia Pacific Market Attractiveness by End User, 2022-2032

Figure 100: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 101: MEA Market Value (US$ Mn) by Transplant Type, 2022-2032

Figure 102: MEA Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 103: MEA Market Value (US$ Mn) by End User, 2022-2032

Figure 104: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Market Value (US$ Mn) Analysis by Transplant Type, 2017-2032

Figure 109: MEA Market Value Share (%) and BPS Analysis by Transplant Type, 2022-2032

Figure 110: MEA Market Y-o-Y Growth (%) Projections by Transplant Type, 2022-2032

Figure 111: MEA Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 112: MEA Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 113: MEA Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 114: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 115: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: MEA Market Attractiveness by Transplant Type, 2022-2032

Figure 118: MEA Market Attractiveness by Disease Indication, 2022-2032

Figure 119: MEA Market Attractiveness by End User, 2022-2032

Figure 120: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Metastatic Bone Tumor Treatment Market

Published : April 2017

Healthcare

Bone Densitometer Devices Market

Published : January 2017

Food and Beverage

Bone and Teeth Supplements Market

Published : January 1970

Google translate

Bone Marrow Transplant Market